The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.

The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.

Previous work has shown an association between the K variant of the butyrylcholinesterase (BCHE) gene and Alzheimer's disease (AD) in patients carrying the epsilon4 allele of ApoE. We attempted to replicate this finding in 181 UK white AD cases and 71 controls. No difference was found in BCHE-K...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Kehoe, P, Williams, H, Holmans, P, Wilcock, G, Cairns, N, Neal, J, Owen, M
Format:	Journal article
Sprog:	English
Udgivet:	1998

Lignende værker

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease.
af: Kehoe, P, et al.
Udgivet: (1999)

Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease.
af: Kehoe, P, et al.
Udgivet: (1996)

Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers
af: Roger M. Lane, et al.
Udgivet: (2024-04-01)

Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.
af: Kehoe, P, et al.
Udgivet: (1996)

Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease.
af: Lehmann, D, et al.
Udgivet: (2000)

Presenilin-1 polymorphism and Alzheimer's disease [6]
af: Kehoe, P, et al.
Udgivet: (1996)

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
af: Holmes, C, et al.
Udgivet: (2005)

Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease.
af: Kehoe, P, et al.
Udgivet: (2004)

ApoE epsilon 2 and butyrylcholinesterase K variant are associated with coronary heart disease in type 2 diabetes
af: Horton, V, et al.
Udgivet: (2000)

Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
af: Blomqvist, M, et al.
Udgivet: (2005)

Butyrylcholinesterase K variant is associated with type 2 diabetes in UK Caucasians
af: Hashim, Y, et al.
Udgivet: (2000)

Association between butyrylcholinesterase K variant and mild cognitive impairment in the Thai community-dwelling patients
af: Pongthanaracht N, et al.
Udgivet: (2017-05-01)

Flavonoids as Inhibitors of Human Butyrylcholinesterase Variants
af: Maja Katalinić, et al.
Udgivet: (2014-01-01)

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
af: Kehoe, P, et al.
Udgivet: (2007)

Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients.
af: Tasker, A, et al.
Udgivet: (2008)

Common variants of ACE contribute to variable age at onset of Alzheimer's disease
af: Katzov, H, et al.
Udgivet: (2004)

Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism.
af: Katzov, H, et al.
Udgivet: (2004)

The renin angiotensin system in Alzheimer's disease - Do updates high-light a clinical and biological dichotomy?
af: Kehoe, P, et al.
Udgivet: (2006)

Obesity and variants of the GHRL (ghrelin) and BCHE (butyrylcholinesterase) genes
af: Vitor G.L. Dantas, et al.
Udgivet: (2011-01-01)

Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: relevance to Alzheimer’s disease treatment
af: Sani Muhammad Uzairu, et al.
Udgivet: (2022-09-01)

Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects.
af: Hashim, Y, et al.
Udgivet: (2001)

Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.
af: Culpan, D, et al.
Udgivet: (2003)

Benzene-1,3-diol derivatives as the inhibitors of butyrylcholinesterase: An emergent target of Alzheimer’s disease
af: Dongliang Yin, et al.
Udgivet: (2022-01-01)

Aaptamine – a dual acetyl – and butyrylcholinesterase inhibitor as potential anti-Alzheimer’s disease agent
af: Shuang Miao, et al.
Udgivet: (2022-12-01)

Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer’s Disease—Could <i>BCHE</i> Genotyping Be Helpful in Alzheimer’s Therapy?
af: Jacek Jasiecki, et al.
Udgivet: (2019-10-01)

TNFR-associated factor-2 (TRAF-2) expression in Alzheimer's disease
af: Culpan, D, et al.
Udgivet: (2004)

The relationship between CAV-1 and cerebral amyloid angiopathy in Alzheimer's disease
af: Chalmers, K, et al.
Udgivet: (2004)

Widely Spread Butyrylcholinesterase Can Hydrolyze Acetylcholine in the Normal and Alzheimer Brain
af: Marsel Mesulam, et al.
Udgivet: (2002-02-01)

Haplotypes extending across ACE are associated with Alzheimer's disease.
af: Kehoe, P, et al.
Udgivet: (2003)

Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer’s disease
af: Chuanyu Yu, et al.
Udgivet: (2024-12-01)

Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease
af: Ana Matošević, et al.
Udgivet: (2022-09-01)

Investigation of Association between Susceptibility to Leprosy and SNPs inside and near the BCHE Gene of Butyrylcholinesterase
af: Henrique J. P. Gomes, et al.
Udgivet: (2012-01-01)

The ACE gene and Alzheimer's disease susceptibility.
af: Narain, Y, et al.
Udgivet: (2000)

Biophenols of mints: Antioxidant, acetylcholinesterase, butyrylcholinesterase and histone deacetylase inhibition activities targeting Alzheimer’s disease treatment
af: Doaa M. Hanafy, et al.
Udgivet: (2017-06-01)

Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors Based on the Pyridyl–Pyridazine Moiety for the Potential Treatment of Alzheimer’s Disease
af: Mohamed Elsawalhy, et al.
Udgivet: (2024-10-01)

Correction: Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka.
af: Leo Pezzementi, et al.
Udgivet: (2011-01-01)

Treating Alzheimer's disease.
af: Wilcock, G, et al.
Udgivet: (1995)

Evolution of acetylcholinesterase and butyrylcholinesterase in the vertebrates: an atypical butyrylcholinesterase from the Medaka Oryzias latipes.
af: Leo Pezzementi, et al.
Udgivet: (2011-02-01)

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.
af: Miners, J, et al.
Udgivet: (2006)

Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease.
af: Culpan, D, et al.
Udgivet: (2007)